These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 30353175)

  • 1. Large-scale reconstruction of cell lineages using single-cell readout of transcriptomes and CRISPR-Cas9 barcodes by scGESTALT.
    Raj B; Gagnon JA; Schier AF
    Nat Protoc; 2018 Nov; 13(11):2685-2713. PubMed ID: 30353175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous single-cell profiling of lineages and cell types in the vertebrate brain.
    Raj B; Wagner DE; McKenna A; Pandey S; Klein AM; Shendure J; Gagnon JA; Schier AF
    Nat Biotechnol; 2018 Jun; 36(5):442-450. PubMed ID: 29608178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous lineage tracing and cell-type identification using CRISPR-Cas9-induced genetic scars.
    Spanjaard B; Hu B; Mitic N; Olivares-Chauvet P; Janjuha S; Ninov N; Junker JP
    Nat Biotechnol; 2018 Jun; 36(5):469-473. PubMed ID: 29644996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas systems: ushering in the new genome editing era.
    Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
    Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly efficient genome editing by homology-directed repair using Cas9 protein in Ceratitis capitata.
    Aumann RA; Schetelig MF; Häcker I
    Insect Biochem Mol Biol; 2018 Oct; 101():85-93. PubMed ID: 30157456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
    Vermersch E; Jouve C; Hulot JS
    Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximizing CRISPR/Cas9 phenotype penetrance applying predictive modeling of editing outcomes in Xenopus and zebrafish embryos.
    Naert T; Tulkens D; Edwards NA; Carron M; Shaidani NI; Wlizla M; Boel A; Demuynck S; Horb ME; Coucke P; Willaert A; Zorn AM; Vleminckx K
    Sci Rep; 2020 Sep; 10(1):14662. PubMed ID: 32887910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome Editing in Zebrafish by ScCas9 Recognizing NNG PAM.
    Liu Y; Liang F; Dong Z; Li S; Ye J; Qin W
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical Control of Genome Editing by Photoactivatable Cas9.
    Otabe T; Nihongaki Y; Sato M
    Methods Mol Biol; 2021; 2312():225-233. PubMed ID: 34228293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas9 in genome editing: Its function and medical applications.
    Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
    J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DEVELOPMENT. CRISPR views of embryos and cells.
    Kupferschmidt K
    Science; 2016 Jun; 352(6290):1156-7. PubMed ID: 27257236
    [No Abstract]   [Full Text] [Related]  

  • 13. CRISPR-Cas9-Mediated Gene Silencing in Cultured Human Epithelia.
    Gago S; Overton NLD; Bowyer P
    Methods Mol Biol; 2021; 2260():37-47. PubMed ID: 33405030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining CRISPR-Cas9 genome-wide nuclease activities with CIRCLE-seq.
    Lazzarotto CR; Nguyen NT; Tang X; Malagon-Lopez J; Guo JA; Aryee MJ; Joung JK; Tsai SQ
    Nat Protoc; 2018 Nov; 13(11):2615-2642. PubMed ID: 30341435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas9 Genome Editing in Human Cell Lines with Donor Vector Made by Gibson Assembly.
    Sahoo N; Cuello V; Udawant S; Litif C; Mustard JA; Keniry M
    Methods Mol Biol; 2020; 2115():365-383. PubMed ID: 32006411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR: development of a technology and its applications.
    Derry WB
    FEBS J; 2021 Jan; 288(2):358-359. PubMed ID: 33300275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology.
    Bai B; Myklebust JH; Wälchli S
    Methods Mol Biol; 2020; 2115():445-454. PubMed ID: 32006416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Generation of Lineage Tracing Dynamically Records Cell Fate Choices.
    Yao M; Ren T; Pan Y; Xue X; Li R; Zhang L; Li Y; Huang K
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications.
    Labuhn M; Adams FF; Ng M; Knoess S; Schambach A; Charpentier EM; Schwarzer A; Mateo JL; Klusmann JH; Heckl D
    Nucleic Acids Res; 2018 Feb; 46(3):1375-1385. PubMed ID: 29267886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.